Doximity (DOCS) Stock Tumbles on Light Forecast, Analysts Slash Price Target but Remain Constructive on Valuation
- Wall Street mints big gains to end strong week
- JP Morgan's Kolanovic Predicts No Recession and Next Week's Rebalancing Could Drive Stocks Up 7%
- U.S. Supreme Court overturns Roe v. Wade, ends constitutional right to abortion
- FedEx (FDX) Gains on Solid FY23 Outlook, Analysts Mostly Bulled Up Into Next Week's Investors Day
- Get Ready for a 10% Rally in S&P 500
Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.
Shares of Doximity (NYSE: DOCS) are down nearly 17% in premarket trading Wednesday after the company issued a weaker-than-expected Q1 revenue forecast.
The company reported FQ4 adjusted EPS of 21c, topping the consensus estimates of 14c per share. Revenue in the fourth quarter stood at $93.7 million, above the expected $90.1 million. Adjusted EBITDA stood at $39,400 in the period, while analysts were looking for $34.9 million
For the first quarter, Doximity expects revenue in the range of $88.6 million to $89.6 million, missing the estimated $96.7 million. Adjusted EBITDA is expected to range between $28.6 million and $29.6 million, compared to the expected $37.3 million.
For FY 2023, the company expects revenue in the range of $454 million to $458 million, topping the analyst expectations of $451.6 million.
Meanwhile, Doximity also approved a new share repurchase plan of $70 million.
Jefferies analyst Glen Santangelo slashed the price target to $46.00 per share from $78.00 to reflect “disappointing” results. Still, the analyst reiterated a Buy rating as valuation is “too attractive to ignore.”
Morgan Stanley analyst Craig Hettenbach also cut the price target to $35.00 per share from $55.00 as a light forecast will overshadow other positive developments.
By Senad Karaahmetovic
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Randstad NV (RAND:NA) (RANJY) PT Lowered to EUR59 at Goldman Sachs
- AENA SME SA (AENA:SM) (ANYYY) PT Lowered to EUR146 at Goldman Sachs
- Symrise AG (SY1:GR) (SYIEY) PT Raised to EUR129 at Goldman Sachs
Create E-mail Alert Related CategoriesAnalyst Comments, Analyst PT Change, Earnings, Guidance, Stock Buybacks
Related EntitiesMorgan Stanley, Jefferies & Co, Senad Karaahmetovic
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!